Related Experiment Videos
[Female patient with Muir-Torre syndrome]
N Negraszus1, K Jöhrens, E Bertelmann
1Klinik für Augenheilkunde, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin. nico.negraszus@charite.de
Abstract:
Muir-Torre syndrome is a rare form of genodermatosis characterized by sebaceous tumours or keratocanthoma and early occurrence of intestinal malignancies. In addition to the patient history immunohistochemical and genetic analysis for microsatellite instability and reduced expression of the mismatch repair gene MSH2 and MLH1 can be used to confirm the diagnosis. Because of this important association, Muir-Torre syndrome should be excluded if a patient presents with a sebaceous tumour.
Insights
Muir-Torre syndrome, a rare genetic skin disorder, links sebaceous tumors to early intestinal cancers. Diagnosis involves genetic testing for mismatch repair gene MSH2 and MLH1 deficiencies.
Area of Science:
- Oncology
- Dermatology
- Genetics
Background:
- Muir-Torre syndrome (MTS) is a rare genodermatosis.
- It is characterized by sebaceous tumors or keratocanthoma and early-onset intestinal malignancies.
Purpose of the Study:
- To highlight the association between sebaceous tumors and internal malignancies.
- To emphasize the importance of considering MTS in patients with sebaceous tumors.
Main Methods:
- Review of patient history.
- Immunohistochemical analysis for microsatellite instability.
- Genetic analysis for mismatch repair gene (MSH2, MLH1) expression.
Main Results:
- Reduced expression of MSH2 and MLH1 genes is indicative of MTS.
- Microsatellite instability is a key diagnostic marker.
Conclusions:
- Muir-Torre syndrome should be suspected in patients presenting with sebaceous tumors.
- Diagnostic confirmation relies on genetic and immunohistochemical analysis.
Related Concept Videos
Disorders of the Female Reproductive System
Mitral Valve Prolapse III: Nursing Management
Cirrhosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse I: Introduction